annb0t
Top 20
If you want to know who really controls Clinuvel Pharmaceuticals Limited (ASX:CUV), then you'll have to look at the makeup of its share registry. We can see that individual investors own the lion's share in the company with 54% ownership. Put another way, the group faces the maximum upside potential (or downside risk).
Institutions, on the other hand, account for 21% of the company's stockholders. Large companies usually have institutions as shareholders, and we usually see insiders owning shar...
>>> Read more: While institutions own 21% of Clinuvel Pharmaceuticals Limited (ASX:CUV), individual investors are its largest shareholders with 54% ownership
Institutions, on the other hand, account for 21% of the company's stockholders. Large companies usually have institutions as shareholders, and we usually see insiders owning shar...
>>> Read more: While institutions own 21% of Clinuvel Pharmaceuticals Limited (ASX:CUV), individual investors are its largest shareholders with 54% ownership
